Page 10 of 11 – SEC Filing
| ITEM 6. | CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. |
Item 6 of the Schedule
13D is hereby supplemented as follows:
The descriptions in
Item 3 and Item 4 are incorporated herein by reference. The summaries of certain provisions of the agreements in this statement
on Schedule 13D are not intended to be complete and are qualified in their entirety by reference to the full text of such agreements.
To the best of the
knowledge of the Reporting Persons, except as provided herein, there are no contracts, arrangements, understandings or relationships
(legal or otherwise), including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures,
loan or option arrangements, puts or calls, guarantees of profits, or the giving or withholding of proxies, between any of the
Reporting Persons, and any other person, with respect to any securities of the Company, including any securities pledged or otherwise
subject to a contingency the occurrence which would give another person voting power or investment power over such securities other
than standard default and similar provisions contained in loan agreements.
| ITEM 7. | MATERIAL TO BE FILED AS EXHIBITS. |
Item 7 of the Schedule
13D is hereby supplemented as follows:
| Exhibit 4 | Agreement and Plan of Merger, dated June 7, 2017, by and among Holdco, Merger Sub and the Company, incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8-K filed by the Company with the SEC on June 8, 2017 | |
| Exhibit 5 | Debt Commitment Letter, dated May 29, 2017, by and among Holdco and Merger Sub and the Lender. | |
| Exhibit 6 | Equity Commitment Letters, dated June 7, 2017, by and between Holdco and GL Sponsor | |
| Exhibit 7 | Equity Commitment Letters, dated June 7, 2017, by and between Holdco and Bank of China Group Investment Limited | |
| Exhibit 8 | Equity | |
| Exhibit 9 | Equity Commitment Letters, dated June 7, 2017, by and between Holdco and Ascendent Capital Partners II, L.P. | |
| Exhibit 10 | Equity Commitment Letters, dated June 7, 2017, by and between Holdco and Mr. Weihang Zhu | |
| Exhibit 11 | Rollover Agreement, dated June 7, 2017, by and among the Rollover Holder, Topco and Holdco | |
| Exhibit 12 | Restated Consortium Agreement, dated June 7, 2017, by and among GL Management, Bank of China Group Investment Limited, Avengers Limited, Ascendent Silver (Cayman) Limited and Boying Investments Limited | |
| Exhibit 13 | Voting and Support Agreement, dated June 7, 2017, by and among the Rollover Holder and the Company, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Company with the SEC on June 8, 2017 | |
| Exhibit 14 | Escrow Agreement, dated June 7, 2017, by and among the Company, Holdco and the Escrow Agent |
| 10 |
Follow Sciclone Pharmaceuticals Inc (NASDAQ:SCLN)
Follow Sciclone Pharmaceuticals Inc (NASDAQ:SCLN)
Receive real-time insider trading and news alerts
